PSL Glass Filter Dryer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PSL Glass Filter Dryer

The GFD® is changing the filtration and drying process in laboratories worldwide. In 2010, the GFD technology was launched combining filtration, cake washing and drying all in one glass vessel.

Working as a miniature agitated nustche filter dryer, this technology allows laboratory development simulating the manufacturing process at a small scale. When the filtration and drying process is validated during R&D, direct scale up is possible first through the three different sizes of GFD then with industrial metallic vessel during pilot plant and commercial production.

In little more than the 3 years since launch over many companies have already adopted this technology worldwide. Applications range from API filtration, peptides washing and drying, simulation for future industrial application, filtration and drying of different deposits sensitive to air or moisture, and most recently microsphere filtration.

Microspheres are small spherical particles, having a required size range. These particles can be manufactured from various natural and synthetic materials such as polymer microspheres. Suspended microspheres obtained from various micro encapsulation processes require being washed, collected by filtration then dried under appropriate conditions to give the final free flowing injectable product. After the process development phase performed with a GFD, direct scale-up is available with PSL Microsphere Refiner product range.

Website: www.powdersystems.com
E-mail: saleseu@powdersystems.com
T: +44 (0)151 448 7700
Stand location: Hall 4.1 Stand J50

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
FindPharma Custom Search

Click here